Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Lunai Bioworks Inc. (LNAI)

Avenue Therapeutics, Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Lunai Bioworks Inc. is the larger, with a market value of $830.0K against $680.0K — 1.2× the size. Avenue Therapeutics, Inc. has the higher net margin (0.00% vs −3,761.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Avenue Therapeutics, Inc. leads on 6 and Lunai Bioworks Inc. on 4.

Valuation

Metric ATXI LNAI Biotechnology median
P/E n/m n/m 10.60
P/S n/m 5.68 9.40
P/B 2.49 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 n/m 0.66
EV/Sales n/m 0.25 9.02
Earnings yield (197.67%) (640.81%) (32.88%)
Free cash flow yield (97.68%) (988.00%) (23.13%)

Profitability

Metric ATXI LNAI Biotechnology median
Gross margin — (3.48%) 68.51%
Operating margin 0.00% (9,184.79%) 0.00%
Net margin 0.00% (3,761.88%) 0.00%
Free cash flow margin 0.00% (5,610.24%) 0.00%
Return on equity (163.30%) 23.46% (51.96%)
Return on assets (90.50%) (39.21%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI LNAI Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.11% 98.77% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 0.11 4.97
Net debt to EBITDA 0.93 0.20 1.01

Dividend

Metric ATXI LNAI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATXI LNAI Biotechnology median
Market cap 680.00k 830.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack